Posted 3/22/2019 12:23 PM (GMT 0)
Great report and glad the results have been so good. I was a student at IU in Bloomington when the accelerator was being built and it was all top secret to be used for research. It was many years later they added the Cancer Treatment Center and it closed a few years ago due to financial reasons. Too expensive to operate and too few people were traveling to Bloomington for treatment. I understand the accelerator is still being used for research, just not doing any cancer treatment.
The PCa proton treatment landscape has changed significantly and it’s use is now uncommon. Proton costs nearly three times what photon costs and the results are no better for either cancer control or limited side effects. Thus third party payors like Medicare and commercial insurance will no longer pay the additional cost. Even ASTRO, the radiation oncology society, updated their care standards last year and stated that it should only be used in trIals to study its effectiveness for PCa.
This is in no way a knock on proton treatment as it has proved very valuable treating many other cancers. It just doesn’t have an advantage in treating PCa. Over the last 20 years the technology has greatly improved photon based treatment with IMRT/IGRT/SBRT/CyberKnife, etc. These improvements have made photon based treatment for PCa effective for cancer control, limited tresatment side effects and cost. A study by UC Berkeley showed the average cost in 2016 for PCa proton treatment to be $69,000 while IMRT/IGRT photon was $29,000.